Ajpendo 00495 2015
Ajpendo 00495 2015
Ajpendo 00495 2015
BREAST MILK IS A COMPLEX BIOLOGICAL FLUID that provides for that contribute to lactation insufficiency. In addition, numerous
optimal infant growth and development, but only if lactation social, psychological, and behavioral factors associated with
functions properly to produce an adequate volume of milk that early breastfeeding cessation have been described, and the
contains optimal amounts of nutritive and nonnutritive factors. reader is referred to excellent reviews on these topics (81, 90,
Successful lactation requires extensive breast tissue expansion 192, 280). What is much less appreciated and poorly under-
and differentiation during pregnancy, followed by the ability to stood is the role that maternal genetics and modifiable factors
produce sufficient amounts of milk after birth. Although ⬃75% such as energy balance, diet, and environmental exposures may
of new mothers intend to breastfeed, not all women are able to have on reproductive endocrinology, lactation physiology, and
breastfeed their infants exclusively for the first 6 mo of life, as the ability to successfully breastfeed. The major unsolved
recommended by the American Academy of Pediatrics and the questions regarding these maternal factors have been outlined
World Health Organization. In fact, it has been estimated that in a recent review (209). In this review, we provide a broad
the prevalence of women who overtly fail to produce enough overview on our current understanding of the molecular etiol-
milk may be as high as ⬃10 –15% (15, 64, 206) and can ogy behind these factors that play a critical role in lactation
quickly lead to hypernatremia (28, 231, 293, 311), nutritional physiology and the ability to optimally nourish the nursing
deficiencies (16, 139, 287), or failure to thrive (141, 164, 207). infant. Because studies in breastfeeding women are profoundly
Moreover, the prevalence of lactation “insufficiency” may be lacking, some aspects and comparisons will be drawn from
much higher, as ⬃40 –50% of women in the US (1, 162) and experimental animal models and studies in production animals
60 –90% of women internationally (76, 99, 113, 135, 266) cite where relevant; however, it is important to note that lactation
“not producing enough milk” or “baby not satisfied with breast physiology between humans and other mammals can vary, and
milk” as the primary reasons for weaning prior to 6 mo. The where appropriate these differences will be discussed in con-
etiology of lactation insufficiency is clearly multifactorial and text.
complex. Breast hypoplasia or other abnormal breast condi-
tions and previous breast surgeries (206) are certainly factors Mammary Gland Biology and the Production of Milk
The mammary gland is a highly complex exocrine gland that
Address for reprint requests and other correspondence: S. L. Kelleher, 500 functions to produce, secrete, and deliver milk to the infant.
University Dr., Hershey, PA (e-mail: [email protected]). Mammary glands are unique in that most development occurs
http://www.ajpendo.org 0193-1849/16 Copyright © 2016 the American Physiological Society E405
Downloaded from journals.physiology.org/journal/ajpendo (114.125.014.149) on July 23, 2023.
Review
E406 ROLE OF GENETICS, DIET, AND ENVIRONMENT ON LACTATION
postnatal. From birth to puberty, the rudimentary branches micronutrients (6). In addition, breast milk contains human
elongate through the mammary fat pad and form terminal end milk oligosaccharides (reviewed in Ref. 269) and numerous
buds in preparation for functional activation during pregnancy growth factors, hormones, chemokines, and cytokines (re-
and lactation. Successful lactation requires coordination of viewed in Ref. 259) as well as DNA, RNA, microRNAs, white
mechanisms responsible for nutrient transport, milk produc- blood cells, and live bacteria (reviewed in Ref. 153) and stem
tion, and secretion from the mammary gland and is driven by cells (reviewed in Ref. 111). Breast milk composition changes
molecular, biochemical, and cellular events that are regulated over the course of lactation. In women, secretory activation
largely by reproductive hormones, which has been described occurs after parturition (30 – 40 h after birth), and the first fluid
thoroughly by Anderson et al. (7). During early pregnancy, produced is colostrum (225). Only a small volume (⬃30 ml/24 h)
primary hormones, including estrogen, progesterone, prolactin, of colostrum is available for the first few days, but contains
and placental lactogen, induce the physiological transition of high concentrations of immunological components such as
the mammary gland from a nonsecreting branched tissue into a secretory IgA, lactoferrin, and leukocytes as well as develop-
highly active secreting organ comprised of a vast network of mental factors such as epidermal growth factor (49, 147, 225).
ducts and alveoli that are grouped into seven to 10 lobes in The concentration of lactose, the most osmotically active
humans (243). Following this morphological change, the alve- component in breast milk, is low in colostrum, thus explaining
olar cells increase the expression of lactogenic genes, which the low volume of colostrum that is secreted and also indicat-
differentiates them into secretory mammary epithelial cells ing that the primary function of colostrum is immunological
(MECs) or lactocytes, and this process is termed secretory rather than nutritional (17). Compared with mature milk, co-
differentiation (225). In response to progesterone and estrogen lostrum contains higher levels of sodium, chloride, and mag-
withdrawal, concomitant with prolactin release following par- nesium and lower levels of potassium and calcium (17, 147,
turition, the differentiated epithelium gains a remarkable ca- 225). As the mammary gland transitions from pregnancy to
pacity to finely coordinate the synthesis and transport of lactation, tight junctions between MECs close, and conse-
various milk constituents for the onset of milk secretion, quently the sodium/potassium ratio declines and the lactose
termed secretory activation (225), which usually occurs after concentration increases (147). This reflects secretory activation
full-term birth in humans (210). During this time, tight junc- and the synthesis of transitional milk, which marks the period
tions between lactocytes close and limit the passage of ions of copious milk production and the secretion of nutritive and
(e.g., sodium and chloride) and small molecules, which is nonnutritive factors to support nutritional and developmental
important for the establishment of lactation and motivating needs of the growing infant. After the first month, breast milk
milk secretion (147, 272). Milk ejection is regulated by oxy- is considered fully mature and contains ⬃0.9 –1.2 g protein/dl,
tocin, which acts on myoepithelial cells to generate contractile 3.2–3.6 g fat/dl, and 6.7–7.8 g lactose/dl (17). Although there
force required for milk ejection during lactation (103). In is a dramatic shift in composition during the first month, the
contrast, milk secretion from lactocytes is regulated by a concentration of macronutrients in breast milk remains rela-
complex hormonal milieu that includes numerous reproductive tively constant over the course of lactation, with gradual
hormones (e.g., prolactin) and metabolic hormones [e.g., glu- increases in milk fat content over the course of one feeding
cocorticoids, insulin, insulin-like growth factor 1 (IGF-I), (17). However, it is important to note that milk composition, as
growth hormone, and thyroid hormone]. These hormones can well as mammary gland number, location, and architecture, is
act directly on the lactocyte or indirectly by altering endocrine different between humans and animals, which is a limitation to
response and nutrient delivery to the mammary gland for milk extrapolating information on human lactation from animal
production (34). The main stimulus for the initiation of studies (2). For example, cattle have a total of four inguinal
lactation is infant suckling and milk removal, which acti- mammary glands producing milk that is higher in protein
vates the milk ejection reflex through the release of oxytocin compared with humans, and mice have four thoracic, two
from the posterior pituitary gland, leading to the contraction abdominal, and four inguinal mammary glands producing milk
of the myoepithelial cells around the alveoli and ducts, ulti- that is higher in protein, fat, and energy compared with humans
mately forcing milk into the alveolar lumen and out the nipple, (2, 128).
providing milk to the developing infant (225). Once lactation As a result of this complex mixture of nutritive and nonnu-
has been established, prolactin secretion from the pituitary tritive factors, numerous studies have shown that breastfed
gland decreases, but milk removal from the mammary gland infants have a lower risk for adverse health consequences,
promotes continuous milk production or galactopoesis (5, 19, including gastroenteritis, pneumonia, childhood obesity, leu-
86, 138, 221). However, as discussed below, both genetic and kemia, and sudden infant death syndrome (124). Therefore, the
modifiable factors may play important roles in the ability of the American Academy of Pediatrics recommends exclusive
breast to respond to infant demand and provide optimal nutri- breastfeeding for the first 6 mo of life. Although breastfeeding
tion for growth and development. initiation rates have increased to ⬃75% in the US, the duration
Breast milk is considered the gold standard for infant feed- of exclusive breastfeeding continues to fall below national
ing, as it provides a perfect combination of nutrient and goals; only 47% of infants are breastfed at all by 6 mo of age,
nonnutritive factors that are essential for infant growth and and of those, only 14% are exclusively breastfed as recom-
development. Breast milk contains a diverse array of proteins, mended (89). For the most part, it is assumed that once
lipids, and carbohydrates that provide energy, bioactive pro- lactation is initiated, a breastfeeding woman can produce
teins (e.g., bile salt stimulated lipase, lactoferrin, lysozyme, enough breast milk that meets the nutritional needs of her
secretory IgA, and ␣-lactalbumin), and both group I (vitamins infant, unless she is severely malnourished. Yet, as noted
A, E, B1, B2, B6, B12, and D as well as choline, selenium, and above, ⬃50% of mothers cite concerns about insufficient milk
iodine) and group II (calcium, iron, copper, zinc, and folate) volume or poor milk quality as motivation to wean their infants
We propose that similar variation may govern lactation missing link between factors involved in milk synthesis and
physiology, milk production, and composition in breastfeeding MEC proliferation, such as glycogen synthase kinase 3
women; however, to date, few studies have explored this (GSK-3) and leucyl-tRNA synthetase (LeuRS) (294, 313). In
possibility. As proof of concept, several mutations in prolactin contrast, AMP-activated protein kinase (AMPK) activation by
and PRLR have been identified in humans (155, 215). In energy depletion in bovine MECs inhibits mTOR signaling and
addition, several studies have found that SNPs in PRLR are decreases milk protein synthesis rate (39). Numerous muta-
associated with elevated serum prolactin levels (rs62355518, tions in genes encoding mTOR components have been identi-
rs10941235, rs1610218, rs34024951, and rs9292575) and in- fied, and the reader is referred to an excellent review by Saxena
creased risk for breast cancer (rs249537, rs7718468 and and Sampson (260) on this topic. Another potential target is the
rs13436213) and gestational diabetes (rs10068521 and peroxisome proliferator-activated receptor-␥ (PPAR␥) path-
rs9292578). Collectively, this suggests that SNPs in PRLR may way, which is critical for the maintenance of the secreting
affect breast function; however, to our knowledge, the effects of mammary epithelium (9) and milk quality by suppressing the
SNPs in PRLR on lactation outcomes have not been explored. production of inflammatory lipids (292). Moreover, PPAR␥
Recently, we identified a woman with a “gain-of-function” variant regulates triglycerol synthesis and secretion in cultured breast
in PRLR (I170L, also known as I146L) who had elevated milk cells (284) and in dairy goats (265). Although SNPs in PPAR␥
zinc concentration (2.82 mg/l; normal ⫽ ⬃1 mg/l) (4). have been identified, are associated with enhanced breast
Subsequent analysis of her milk composition determined density, and are modified by diet (157), no clear relationship
that the ratio of sodium to potassium was also elevated with lactation outcomes (226) has yet been identified. Going
(⬃0.9; Kelleher SL, unpublished data), also suggesting forward, it will be important to differentiate between problems
subclinical breast dysfunction (263). Moreover, a “loss-of- resulting from inadequate mammary gland development during
function” variant in PRLR (H188R) results in secondary puberty or inadequate secretory development in pregnancy
hyperprolactinemia and is associated with persistent galac- from those that impact secretory activation or secretion of milk
torrhea (212). Genetic variation in downstream molecules components.
that elicit prolactin signaling may also be important candi- Other hormones and endocrine factors/inhibitors. In addi-
dates. Gain-of-function mutations in Jak2 (V617F) and tion to prolactin, a complex combination of hormones works
STAT5B have been identified in humans (18, 239). Constitu- together to maintain the differentiated epithelium and milk
tive activation of Jak2 through expression of V617F in mice secretion during lactation, including insulin, glucocorticoids,
elevates STAT5 signaling and promotes alveologenesis, al- growth hormone, oxytocin, and thyroid hormone. Secretory
though lactation outcomes in women expressing V617F have activation and milk ejection require insulin and glucocorticoids
not been investigated. Clearly, a profound lack of understand- to synergistically regulate the formation of tight junctions in
ing exists regarding the consequences of genetic variation in the mammary gland (223, 312), stimulate mammary differen-
the prolactin-Jak2/STAT5 signaling pathway on lactation out- tiation (48), and induce milk protein expression (73). Insulin
comes. Collectively, these observations suggest that alterations levels rapidly decrease during early lactation and steadily
in prolactin signaling pathways may affect breast function and increase over time (301). Recent work shows that insulin in the
lactation outcomes and warrant further investigation. The fact presence of prolactin and hydrocortisone plays a pivotal role in
that recombinant prolactin has successfully been used to in- regulating milk protein synthesis in mammary explants from
crease milk volume and lactose, calcium, and oligosaccharide animals by increasing the expression of transcription factors
concentrations in some women, but with limited success in Elf5 and STAT5 (193, 194). Studies in dairy cows show
others (235), suggests that pharmacogenomics targeted at this conflicting effects of exogenous insulin on milk fat levels,
pathway may be an approach to improve lactation outcomes in where long-lasting insulin treatment tends to increase milk fat
some women in the future. content and milk yield (305), whereas hyperglycemic insulin
Other cell signaling pathways. Apart from prolactin signal- clamp reduces milk fat and milk yield (61, 173). Similarly,
ing, the mammary gland possesses a network of signaling women with gestational diabetes who are on insulin therapy
pathways that detect metabolic status, regulate gene transcrip- have a delay in the onset of secretory activation (179), which
tion and milk protein synthesis, and maintain many cellular suggests that insulin treatment may have adverse effects on
processes during lactation. One such pathway is the mamma- milk production or composition in humans.
lian target of rapamycin (mTOR) pathway, which has a well- In contrast, growth hormone deficiency compromises lacta-
established role in regulating protein synthesis by phosphory- tion outcomes in rats, as it reduces milk yield by ⬃24% (83).
lating eukarytoric translation factor 4E binding protein 1 (4E- Moreover, artificial growth hormone or recombinant bovine
BP1), thereby releasing eukaryotic translation initiation factor somatotropin administration to ewes (56, 256) and dairy cows
4E (eiF4E) to regulate translation (296). The mTOR pathway is (91, 188, 230) increases milk protein yield and milk volume,
a well-known therapeutic target for breast cancer (154), and and growth hormone has been used as a pharmacological agent
emerging studies also illustrate the importance of mTOR in to augment milk production in women (100, 198). It is spec-
modulating lactation outcomes. Inhibition of mTOR signaling ulated that this occurs through the activation of cell prolifera-
using RAD001 during lactation markedly impairs lactation tion (174) and through increased STAT5 expression (33).
(87). Moreover, a role for mTOR signaling in milk protein Genetic variation in growth hormone receptors has recently
synthesis has been demonstrated recently (10, 11, 38, 39, 294, been associated with milk production traits in dairy cattle (51,
313), as synthesis of proteins like -lactoglobulin in bovine 240), sheep (175), and water buffalo (264). Although numer-
mammary glands (201) or ␣-s1 casein in bovine mammary ous SNPs in growth hormone, its cognate receptor, placental
cells (309) is upregulated through the phosphorylation of lactogen, and placental growth hormone have been identified in
4E-BP1. The mTOR pathway has also been shown to be the humans, to our knowledge, genetic variation in this pathway
lactose may underlie the phenotype of reduced milk secretion development and susceptibility to allergies during infancy
and milk zinc levels in ZnT4-null mice (186). However, a (169, 283, 286). Maternal fatty acid intake not only affects the
much more impressive phenotype in ZnT4-null mice is the fatty acid profile of human milk but has also been shown to be
dramatic loss in alveolar structure and activation of precocious an important dietary determinant of mammary gland function.
involution and early lactation failure (186); thus more research For example, MECs of rats fed a LCPUFA-deficient diet are
is required to understand the role of ZnT4 in lactation physi- unresponsive to prolactin stimulation and have impaired secre-
ology and how the lactocyte regulates zinc transport to meet its tion resulting from low phospholipid levels in the mammary
unique physiological needs. Given the role of genetic variation gland and accumulation of secretory vesicles in the cytoplasm
in ZnT2 (and perhaps other zinc transporters) in modifying (219). This suggests that low intake of LCPUFAs may have
milk zinc levels, further studies are needed to determine the profound effects on milk volume and composition. Moreover,
contribution of maternal genetics to regulating zinc homeosta- medium-chain fatty acids (C:8 –C14:0) are found in breast
sis during times of zinc deficiency or excess. Finally, the other milk, and the concentration increases over the duration of
mineral that is of global concern is iodine. In the mammary lactation (13, 82, 104). Medium-chain fatty acids are synthe-
gland, iodide transport is mediated by the sodium/iodide sym- sized in the mammary gland through de novo fatty acid
porter (NIS) (251, 281), and the concentration of milk iodine synthesis, which is catalyzed by the enzyme fatty acid synthase
varies widely, ranging from 5.4 to 2,170 g/l, reflecting the (FASN) (278, 314). In addition to reduced milk fatty acids,
lack of homeostasis (74). This not only affects infant iodine FASN-deficient mice showed defects in mammary develop-
nutrition but can also have profound effects on breast physi- ment and underwent precocious involution (278). Recent stud-
ology, resulting in mammary dysplasia and atypia due to ies reveal genomic variability and functional expression of the
atrophy and necrosis in the alveolar cells (78, 275), most likely FASN gene in buffalo and found the highest expression of
through alterations in the production, secretion, and activity of FASN1 in mammary gland during lactation when fat turnover
thyroid hormones. As noted above, further studies are needed is the greatest (214), which implicates its importance in the
to better understand effects of hypo- and hyperthyroidism on active stage of milk production (190). Genetic variations in
lactation outcomes and milk composition. In contrast to iodine, other genes that govern fatty acid metabolism have been shown
maternal intake of calcium does not directly affect calcium to have a profound impact on milk composition and infant
levels in breast milk (123) because a large amount of calcium health outcomes. A T347S variant of apolipoprotein A4, which
is drawn from the bone (144) to transfer ⬃300 – 400 mg is involved in dietary fat absorption, is present in about one-
calcium/day into milk (142). Therefore, dietary calcium intake third of the US population, and women with this variant have
prior to pregnancy may be most critical for providing calcium a greater level of DHA in their breast milk (98, 222). More-
for milk secretion during lactation and has been reviewed over, 20% of the population carries one or two copies of the E4
recently by Kovacs (143). This large amount of calcium is variant of the apoliprotein E gene, which regulates circulating
secreted by forming a complex with citrate, casein, or phos- fat metabolism, and women with the E4 variant have signifi-
phates that are packaged into secretory vesicles for exocytosis cantly less milk fat than women without this variant (132, 268).
(208) or by direct transport across the apical membrane The most well-studied genetic variants are SNPs in fatty acid
through calcium ATPase type 2 (248). For an excellent review desaturase 1 and 2 (FADS1 and FADS2), which encode the
on calcium transport in the breast during lactation, the reader is enzymes ⌬5 and ⌬6 desaturases, respectively, and are rate-
referred to Cross et al. (65). limiting enzymes in the synthesis of polyunsaturated -3 and
Protein and amino acids. In addition to vitamins and min- -6 fatty acids (arachidonic acid, eicosapentaenoic acid, and
erals, protein deficiencies have been reported to reduce milk DHA). Several SNPs in FADS1 and FADS2 in Canadian
production (14). Rats fed an arginine-deficient diet had im- Holstein cows (121) and breastfeeding women (308) are asso-
paired mammary gland growth (228). Moreover, excess protein ciated with alterations in milk fatty acid composition. Impor-
intake in lactating mice decreases mammary gland mass, re- tantly, these alterations have critical implications for infant
duces expression of major milk constituents, and lowers milk health and development, as an interaction between exclusive
lactose concentration (146). Milk lactose and milk fat are breastfeeding and asthma modified by FADS genotypes in
essential components in milk that reflect the capacity for children has been noted (271). Furthermore, breastfeeding,
secretory activation, milk synthesis, and milk quality; there- FADS genotype, and fish intake are important determinants of
fore, when dietary glucose (a precursor for lactose synthesis) or DHA status in late infancy (110). This may be particularly
fatty acids are restricted, substantial impacts on milk compo- important given the role of EPA and DHA in neurological
sition (protein, fat, and glucose) and mammary gland growth development during infancy, which has been elegantly re-
occur in lactating rat dams (150). However, it is not clear viewed by Innis (122).
whether dietary glucose restriction will affect lactation in
women, because studies in developing countries of women Role of Environmental Factors on Mammary Gland
with poor diets have shown no effect on milk output (62). Physiology
Fatty acids. Milk fat is a major source of energy and
fat-soluble vitamins as well as essential fatty acids (31, 82) In addition to genetics and diet, environmental factors may
Fatty acid composition in milk is species specific and is contribute to suboptimal lactation (26, 35, 79, 211). Many of
extremely sensitive to maternal nutrition and dietary alterations these environmental chemicals have become a part of our daily
(82, 227). In particular, long-chain polyunsaturated fatty acids diet and exposures, especially since they are often found at
(LCPUFAs) such as docosahexaenoic acid (DHA), ecosopen- high concentrations in fat-containing food such as red meat and
tanoic acid (EPA), and arachidonic acid in breast milk are dairy products (191). Constant exposure to various chemicals
obtained from maternal diet and are implicated in neurological in the environment can put a toxic burden upon the body, and
Milk Milk
Fig. 1. Maternal factors that can lead to lactation insufficiency. Lactation insufficiency is a condition in which lactation is insufficient or unsuccessful due to
inadequate milk production. A and B: images of hematoxylin and eosin-stained mouse mammary gland tissues represent a functional mammary gland undergoing
successful lactation (A) and a mammary gland with impaired mammary differentiation and milk secretion that results in lactation insufficiency (B). C: list
summarizing genetic, dietary, and environmental factors that have been shown to affect lactation outcomes. PRLR, prolactin receptor; Jak2, Janus kinase 2;
SOCS2, suppressor of cytokine signaling 2; STAT, signal transducer and activator of transcription; ATF4, activating transcription factor 4; IGFBP-4, insulin-like
growth factor-binding protein 4; IRF1, interferon regulatory factor 1; LIFR, leukemia inhibitory factor receptor; OSMR, oncostatin M receptor; PTK2, protein
tyrosine kinase 2; mTOR, mammalian target of rapamycin; Gsk3, glycogen synthase kinase 3; LeuRS, leucyl-tRNA synthetase; PPAR␥, peroxisome
proliferator-activated receptor-␥; GH, growth hormone; OXTR, oxytocin receptor; FGF2, fibroblast growth factor 2; VDR, vitamin D receptor; ZnT2, zinc
transporter 2; DGAT1, diacylglycerol O-acyltransferase 1; apo4, apolipoprotein 4; apoE, apolipoprotein E; FADS, fatty acid desaturase; LCPUFA, long-chain
polyunsaturated fatty acids; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; MCFA, medium-chain fatty acid; AA, arachidonic Acid; BPA, bisphenol
A; PBDE, polybrominated diphenyl ethers (PBDE); PFOA, perfluorooctanoic acid; PCDD, polychlorinated dibenzo-p-dioxins; PCDF, polychlorinated
dibenzofurans; PCB, polychlorinated biphenyls; DDE, dichlorodiphenyl dichloroethene.
cause adverse effects on mammary gland development and to investigate potential ways to reduce transfer into milk or to
lactation (80). Numerous chemicals such as atrazine and dioxin buffer these harmful factors in infants (191).
(in herbicides), bisphenol A (BPA), and dibutylphthalate (in
plastics), nonylphenol (in laundry and dish detergent), poly- Conclusion
brominated diphenyl ethers (a flame retardant), and perfluo- Breast milk clearly provides optimal nutrition for the grow-
rooctanoic acid (PFOA; in cleaning products and pesticides) ing infant as long as the mother is capable of producing and
have been observed to disrupt mammary gland function. Di- secreting an adequate volume of high-quality milk. Epidemi-
oxins or dioxin-like compounds are comprised of members of ological studies suggest that many breastfeeding women may
three structurally related families of chemicals: polychlorinated suffer from suboptimal lactation, and increasing evidence im-
dibenzo-p-dioxins, polychlorinated dibenzofurans, and poly- plicates maternal genetics, diet, and environmental toxins as
chlorinated biphenyls (PCBs). Dioxins activate the aryl hydro- modifiers of reproductive endocrinology, mammary gland
carbon receptor, which increases expression of numerous physiology, lactation, and milk composition (Fig. 1). Although
genes, including ABCG2, which is the main xenobiotic trans- infant formula meets the nutritional needs of infants, there
porter in the mammary gland (106). PFOA is a known agonist remain clear differences in short- and long-term health out-
of PPAR␣, which profoundly impairs normal differentiation of comes between breast-fed and formula-fed infants. Clearly,
lobular-alveolar units during lactation (310). Studies in rodents understanding factors that impact lactation and developing
show that gestational exposure to dioxins (290), PFOA (299, methods to accurately assess lactation outcomes before a
300), atrazine (247), and BPA (180) leads to changes in breast-fed infant becomes ill will directly inform the develop-
mammary gland development that include mammary hypopla- ment of therapeutic strategies to improve poor lactation per-
sia, reduced apoptosis in terminal end buds, altered gene or formance. Importantly, these advancements will have a major
protein expression, and accelerated alveolar differentiation. In impact on increasing the number of exclusively breastfed
addition, mice exposed to dioxins during gestation have acti- infants and decreasing the burden of noncommunicable dis-
vated aryl hydrocarbon receptor, severe defects in mammary ease. Moreover, understanding these factors and improving
gland differentiation during lactation, and reduced milk protein lactation success will be important to develop novel nutrig-
expression that leads to offspring death within 24 h postpartum enomic or pharmacogenomic approaches for reducing breast
(290). PFOA exposure in mice during early gestation or lac- disease and cancer.
tation permanently impairs mammary gland differentiation,
GRANTS
reduces milk protein expression, and decreases pup survival
over the lactation period (300). Finally, exposure to BPA This work was supported in part by NIHD058614 to S. L. Kelleher,
intramural support from the Penn State Hershey Department of Surgery to S. L.
during pregnancy in mice leads to lactation insufficiency and Kelleher, and the Huck Dissertation Research Award from the Huck Institute
offspring death (180). Thus far, only a few studies in women of Life Sciences at Penn State University to S. Lee.
have shown an association between toxins like PCBs and
dichlorodiphenyl dichloroethene and lactation defects such that DISCLOSURES
exposure to these toxins is associated with shorter breastfeed- No conflicts of interest, financial or otherwise, are declared by the authors.
ing duration (67, 252). Given the burden of these often hidden
AUTHOR CONTRIBUTIONS
environmental toxins in daily life, understanding the conse-
quences of these environmental toxins on mammary gland S.L. and S.L.K. prepared figures; S.L. and S.L.K. drafted manuscript; S.L.
physiology in humans is an important area for future research. and S.L.K. edited and revised manuscript; S.L. and S.L.K. approved final
version of manuscript.
The toxins mentioned above are man-made environmental
contaminants, but even natural components such as heavy REFERENCES
metals exposure can affect the mammary gland during lacta-
1. Ahluwalia IB, Morrow B, Hsia J. Why do women stop breastfeeding?
tion. Some heavy metals (copper, zinc, and manganese) are Findings from the Pregnancy Risk Assessment and Monitoring System.
biologically essential; however, the most pollutant heavy met- Pediatrics 116: 1408 –1412, 2005.
als are lead, cadmium, and mercury that bioaccumulate follow- 2. Akers RM. Lactation and the Mammary Gland. Hoboken, NJ: Wiley-
ing absorption, causing adverse health effects. Human, rumi- Blackwell, 2002.
3. Akinci A, Kanaka C, Eble A, Akar N, Vidinlisan S, Mullis PE.
nant, and rodent studies have all demonstrated that cadmium Isolated growth hormone (GH) deficiency type IA associated with a
levels remain low in breast milk, suggesting that the mammary 45-kilobase gene deletion within the human GH gene cluster. J Clin
gland is capable of protecting the growing infant from heavy Endocrinol Metab 75: 437–441, 1992.
metal exposure (24, 25, 85, 105, 170, 232, 270). As a result, 4. Alam S, Hennigar SR, Gallagher C, Soybel DI, Kelleher SL. Exome
Sequencing of SLC30A2 Identifies Novel Loss- and Gain-of-Function
cadmium sequestration in the mammary glands of lactating Variants Associated with Breast Cell Dysfunction. J Mammary Gland
rodents has been observed (232), which disturbs alveoli mor- Biol Neoplasia 20: 159 –172, 2015.
phology and reduces -casein production and secretory acti- 5. Aljazaf K, Hale TW, Ilett KF, Hartmann PE, Mitoulas LR, Kris-
vation (217). Although these studies illustrate profound lacta- tensen JH, Hackett LP. Pseudoephedrine: effects on milk production in
women and estimation of infant exposure via breastmilk. Br J Clin
tion defects resulting from these environmental factors, there Pharmacol 56: 18 –24, 2003.
remains conflicting information regarding the mechanistic ex- 6. Allen LH. B vitamins in breast milk: relative importance of maternal
planation(s) (180, 290). Hence, the mechanism of action(s) of status and intake, and effects on infant status and function. Adv Nutr 3:
heavy metals on breast development and lactation outcomes 362–369, 2012.
7. Anderson SM, MacLean PS, McManaman JL, Neville MC. Lactation
still remains to be explored. More importantly, because expo- and its hormonal control. In: Knobil and Neill’s Physiology of Repro-
sures to heavy metals as well as environmental toxins have duction, edited by Plant TM and Zelenick AJ. Atlanta, GA: Elsevier,
become inevitably common, it is of much greater significance 2014, p. 2055–2105.
52. Chapman DJ, Pérez-Escamilla R. Does delayed perception of the onset promoter constructs in a mammary epithelial cell line. Proc Natl Acad
of lactation shorten breastfeeding duration? J Hum Lact 15: 107–111; Sci USA 86: 104 –108, 1989.
quiz 137–139, 1999. 74. Dorea JG. Iodine nutrition and breast feeding. J Trace Elem Med Biol
53. Chen CC, Stairs DB, Boxer RB, Belka GK, Horseman ND, Alvarez 16: 207–220, 2002.
JV, Chodosh LA. Autocrine prolactin induced by the Pten-Akt pathway 75. Dumrongwongsiri O, Suthutvoravut U, Chatvutinun S, Phoonlabda-
is required for lactation initiation and provides a direct link between the cha P, Sangcakul A, Siripinyanond A, Thiengmanee U, Chongviri-
Akt and Stat5 pathways. Genes Dev 26: 2154 –2168, 2012. yaphan N. Maternal zinc status is associated with breast milk zinc
54. Chew BP, Zamora CS, Luedecke LO. Effect of vitamin A deficiency concentration and zinc status in breastfed infants aged 4 – 6 months. Asia
on mammary gland development and susceptibility to mastitis through Pac J Clin Nutr 24: 273–280, 2015.
intramammary infusion with Staphylococcus aureus in mice. Am J Vet 76. El Shafei AM, Labib JR. Determinants of exclusive breastfeeding and
Res 46: 287–293, 1985. introduction of complementary foods in rural Egyptian communities.
55. Chierici R, Saccomandi D, Vigi V. Dietary supplements for the lactat- Glob J Health Sci 6: 236 –244, 2014.
ing mother: influence on the trace element content of milkarticle-title⬎. 77. Emerman JT, Leahy M, Gout PW, Bruchovsky N. Elevated growth
Acta Paediatr Suppl 88: 7–13, 1999. hormone levels in sera from breast cancer patients. Horm Metab Res 17:
56. Chiofalo VB, Savoini G, Polidori F, Dell’Orto V, Politis I. Response 421–424, 1985.
of dairy ewes in late lactation to recombinant bovine somatotropin. Small 78. Eskin BA, Bartuska DG, Dunn MR, Jacob G, Dratman MB. Mam-
Rumin Res 34: 119 –125, 1999. mary gland dysplasia in iodine deficiency. Studies in rats. JAMA 200:
57. Chowanadisai W, Kelleher SL, Nemeth JF, Yachetti S, Kuhlman CF, 691–695, 1967.
Jackson JG, Davis AM, Lien EL, Lonnerdal B. Detection of a single 79. Euling SY, Selevan SG, Pescovitz OH, Skakkebaek NE. Role of
nucleotide polymorphism in the human alpha-lactalbumin gene: impli- environmental factors in the timing of puberty. Pediatrics 121, Suppl 3:
cations for human milk proteins. J Nutr Biochem 16: 272–278, 2005. S167–S171, 2008.
58. Chowanadisai W, Lonnerdal B, Kelleher SL. Identification of a 80. Fenton SE. Endocrine-disrupting compounds and mammary gland de-
mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentra- velopment: early exposure and later life consequences. Endocrinology
tion that results in transient neonatal zinc deficiency. J Biol Chem 281: 147: S18 –S24, 2006.
39699 –39707, 2006. 81. Figueiredo B, Dias CC, Brandão S, Canário C, Nunes-Costa R.
59. Cole JB, VanRaden PM, O’Connell JR, Van Tassell CP, Sonstegard Breastfeeding and postpartum depression: state of the art review. J
TS, Schnabel RD, Taylor JF, Wiggans GR. Distribution and location Pediatr (Rio J) 89: 332–338, 2013.
of genetic effects for dairy traits. J Dairy Sci 92: 2931–2946, 2009. 82. Finley DA, Lonnerdal B, Dewey KG, Grivetti LE. Breast milk com-
60. Colodro-Conde L, Zhu G, Power RA, Henders A, Heath AC, Mad- position: fat content and fatty acid composition in vegetarians and
den PA, Montgomery GW, Medland S, Ordonana JR, Martin NG. A non-vegetarians. Am J Clin Nutr 41: 787–800, 1985.
twin study of breastfeeding with a preliminary genome-wide association 83. Flint DJ, Gardner M. Evidence that growth hormone stimulates milk
scan. Twin Res Hum Genet 18: 61–72, 2015. synthesis by direct action on the mammary gland and that prolactin exerts
61. Corl BA, Butler ST, Butler WR, Bauman DE. Short communication: effects on milk secretion by maintenance of mammary deoxyribonucleic
Regulation of milk fat yield and fatty acid composition by insulin. J acid content and tight junction status. Endocrinology 135: 1119 –1124,
Dairy Sci 89: 4172–4175, 2006. 1994.
62. Coward WA, Paul AA, Prentice AM. The impact of malnutrition on 84. Flint DJ, Travers MT, Barber MC, Binart N, Kelly PA. Diet-induced
human lactation: observations from community studies. Fed Proc 43: obesity impairs mammary development and lactogenesis in murine mam-
2432–2437, 1984. mary gland. Am J Physiol Endocrinol Metab 288: E1179 –E1187, 2005.
63. Cregan MD, De Mello TR, Kershaw D, McDougall K, Hartmann PE. 85. Floris B, Bomboi G, Sechi P, Pirino S, Marongiu ML. Cadmium
Initiation of lactation in women after preterm delivery. Acta Obstet chronic administration to lactating ewes: reproductive performance, cad-
Gynecol Scand 81: 870 –877, 2002. mium tissue accumulation and placental transfer. Ann Chim 90: 703–708,
64. Cromi A, Serati M, Candeloro I, Uccella S, Scandroglio S, Agosti M, 2000.
Ghezzi F. Assisted reproductive technology and breastfeeding outcomes: 86. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure,
a case-control study. Fertil Steril 103: 89 –94, 2015. function, and regulation of secretion. Physiol Rev 80: 1523–1631, 2000.
65. Cross BM, Breitwieser GE, Reinhardt TA, Rao R. Cellular calcium 87. Fu NY, Rios AC, Pal B, Soetanto R, Lun AT, Liu K, Beck T, Best SA,
dynamics in lactation and breast cancer: from physiology to pathology. Vaillant F, Bouillet P, Strasser A, Preiss T, Smyth GK, Lindeman
Am J Physiol Cell Physiol 306: C515–C526, 2014. GJ, Visvader JE. EGF-mediated induction of Mcl-1 at the switch to
66. Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX, Robinson lactation is essential for alveolar cell survival. Nat Cell Biol 17: 365–375,
GW, Hennighausen L. Inactivation of Stat5 in mouse mammary epi- 2015.
thelium during pregnancy reveals distinct functions in cell proliferation, 88. Garcia-Fernandez M, Gutierrez-Gil B, Garcia-Gamez E, Sanchez
survival, and differentiation. Mol Cell Biol 24: 8037–8047, 2004. JP, Arranz JJ. Detection of quantitative trait loci affecting the milk fatty
67. Cupul-Uicab LA, Gladen BC, Hernandez-Avila M, Weber JP, Long- acid profile on sheep chromosome 22: role of the stearoyl-CoA desatu-
necker MP. DDE, a degradation product of DDT, and duration of rase gene in Spanish Churra sheep. J Dairy Sci 93: 348 –357, 2010.
lactation in a highly exposed area of Mexico. Environ Health Perspect 89. Gartner LM, Morton J, Lawrence RA, Naylor AJ, O’Hare D,
116: 179 –183, 2008. Schanler RJ, Eidelman AI; American Academy of Pediatrics Section
68. Daley AJ, Thomas A, Cooper H, Fitzpatrick H, McDonald C, Moore on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics
H, Rooney R, Deeks JJ. Maternal exercise and growth in breastfed 115: 496 –506, 2005.
infants: a meta-analysis of randomized controlled trials. Pediatrics 130: 90. Gilmour C, Hall H, McIntyre M, Gillies L, Harrison B. Factors
108 –114, 2012. associated with early breastfeeding cessation in Frankston, Victoria: a
69. Dangat KD, Kale AA, Joshi SR. Maternal supplementation of omega 3 descriptive study. Breastfeed Rev 17: 13–19, 2009.
fatty acids to micronutrient-imbalanced diet improves lactation in rat. 91. Gohary K, LeBlanc SJ, Lissemore KD, Overton MW, Von Massow
Metabolism 60: 1318 –1324, 2011. M, Duffield TF. Effect of prepartum administration of recombinant
70. Daniels KM, Farmer C, Jimenez-Flores R, Rijnkels M. Lactation bovine somatotropin on health and performance of lactating dairy cows.
Biology Symposium: the long-term impact of epigenetics and maternal J Dairy Sci 97: 6231–6241, 2014.
influence on the neonate through milk-borne factors and nutrient status. 92. Gopalan C. Effect of nutrition on pregnancy and lactation. Bull World
J Anim Sci 91: 673–675, 2013. Health Organ 26: 203–211, 1962.
71. Dewey KG, Lonnerdal B. Breast milk intake: variations in breast- 93. Gorski J. Endocrine factors in genetic improvement of milk production.
feeding practices. Am J Clin Nutr 38: 152–153, 1983. J Dairy Sci 62: 814 –817, 1979.
72. Dewey KG, Lovelady CA, Nommsen-Rivers LA, McCrory MA, 94. Gregory RL, Wallace JP, Gfell LE, Marks J, King BA. Effect of
Lonnerdal B. A randomized study of the effects of aerobic exercise by exercise on milk immunoglobulin A. Med Sci Sports Exerc 29: 1596 –
lactating women on breast-milk volume and composition. N Engl J Med 1601, 1997.
330: 449 –453, 1994. 95. Grigor MR, Gain KR. The effect of starvation and refeeding on
73. Doppler W, Groner B, Ball RK. Prolactin and glucocorticoid hormones lipogenic enzymes in mammary glands and livers of lactating rats.
synergistically induce expression of transfected rat beta-casein gene Biochem J 216: 515–518, 1983.
kappa-casein gene of Indian native cattle (Bos indicus) and buffalo 163. Lim HY, Im KS, Kim NH, Kim HW, Shin JI, Sur JH. Obesity,
(Bubalus bubalis). Meta Gene 2: 769 –781, 2014. expression of adipocytokines, and macrophage infiltration in canine
141. Koletzko B, Aggett PJ, Bindels JG, Bung P, Ferre P, Gil A, Lentze mammary tumors. Vet J 203: 326 –331, 2015.
MJ, Roberfroid M, Strobel S. Growth, development and differentiation: 164. Livingstone VH. Problem-Solving Formula for Failure to Thrive in
a functional food science approach. Br J Nutr 80, Suppl 1: S5–S45, 1998. Breast-fed Infants. Can Fam Physician 36: 1541–1545, 1990.
142. Kovacs CS. Calcium and bone metabolism during pregnancy and lacta- 165. Lonnerdal B. Trace element transport in the mammary gland. Annu Rev
tion. J Mammary Gland Biol Neoplasia 10: 105–118, 2005. Nutr 27: 165–177, 2007.
143. Kovacs CS. Maternal Mineral and Bone Metabolism During Pregnancy, 166. Lovelady C. Balancing exercise and food intake with lactation to
Lactation, and Post-Weaning Recovery. Physiol Rev 96: 449 –547, 2016. promote post-partum weight loss. Proc Nutr Soc 70: 181–184, 2011.
144. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metab- 167. Lovelady CA, Fuller CJ, Geigerman CM, Hunter CP, Kinsella TC.
olism during pregnancy, puerperium, and lactation. Endocr Rev 18: Immune status of physically active women during lactation. Med Sci
832–872, 1997. Sports Exerc 36: 1001–1007, 2004.
145. Krebs NF, Reidinger CJ, Hartley S, Robertson AD, Hambidge KM. 168. Lovelady CA, Lonnerdal B, Dewey KG. Lactation performance of
Zinc supplementation during lactation: effects on maternal status and exercising women. Am J Clin Nutr 52: 103–109, 1990.
milk zinc concentrations. Am J Clin Nutr 61: 1030 –1036, 1995. 169. Lowe AJ, Thien FC, Stoney RM, Bennett CM, Hosking CS, Hill DJ,
146. Kucia M, Langhammer M, Gors S, Albrecht E, Hammon HM, Carlin JB, Abramson MJ, Dharmage SC. Associations between fatty
Nurnberg G, Metges CC. High-protein diet during gestation and lacta- acids in colostrum and breast milk and risk of allergic disease. Clin Exp
tion affects mammary gland mRNA abundance, milk composition and Allergy 38: 1745–1751, 2008.
pre-weaning litter growth in mice. Animal 5: 268 –277, 2011. 170. Lucis OJ, Lucis R, Shaikh ZA. Cadmium and zinc in pregnancy and
147. Kulski JK, Hartmann PE. Changes in human milk composition during lactation. Arch Environ Health 25: 14 –22, 1972.
the initiation of lactation. Aust J Exp Biol Med Sci 59: 101–114, 1981. 171. Lundqvist C, Zuurbier M, Leijs M, Johansson C, Ceccatelli S,
148. La Vecchia C, Giordano SH, Hortobagyi GN, Chabner B. Over- Saunders M, Schoeters G, ten Tusscher G, Koppe JG. The effects of
weight, obesity, diabetes, and risk of breast cancer: interlocking pieces of PCBs and dioxins on child health. Acta Paediatr Suppl 95: 55–64, 2006.
the puzzle. Oncologist 16: 726 –729, 2011. 172. Mach N, Blum Y, Bannink A, Causeur D, Houee-Bigot M, Lagarri-
149. LaKind JS, Berlin CM Jr, Sjodin A, Turner W, Wang RY, Needham gue S, Smits MA. Pleiotropic effects of polymorphism of the gene
LL, Paul IM, Stokes JL, Naiman DQ, Patterson DG Jr. Do human diacylglycerol-O-transferase 1 (DGAT1) in the mammary gland tissue of
milk concentrations of persistent organic chemicals really decline during dairy cows. J Dairy Sci 95: 4989 –5000, 2012.
lactation? Chemical concentrations during lactation and milk/serum par- 173. Mackle TR, Dwyer DA, Bauman DE. Intramammary infusion of
titioning. Environ Health Perspect 117: 1625–1631, 2009. insulin or long R3 insulin-like growth factor-I did not increase milk
150. Lanoue L, Koski KG. Glucose-restricted diets alter milk composition protein yield in dairy cows. J Dairy Sci 83: 1740 –1749, 2000.
and mammary gland development in lactating rat dams. J Nutr 124: 174. Maningat PD, Sen P, Rijnkels M, Hadsell DL, Bray MS, Haymond
94 –102, 1994. MW. Short-term administration of rhGH increases markers of cellular
proliferation but not milk protein gene expression in normal lactating
151. Laporta J, Penagaricano F, Hernandez LL. Transcriptomic Analysis
women. Physiol Genomics 43: 381–391, 2011.
of the Mouse Mammary Gland Reveals New Insights for the Role of
175. Marques Mdo R, Santos IC, Carolino N, Belo CC, Renaville R,
Serotonin in Lactation. PLoS One 10: e0140425, 2015.
Cravador A. Effects of genetic polymorphisms at the growth hormone
152. Lasry I, Golan Y, Berman B, Amram N, Glaser F, Assaraf YG. In situ
gene on milk yield in Serra da Estrela sheep. J Dairy Res 73: 394 –405,
dimerization of multiple wild type and mutant zinc transporters in live
2006.
cells using bimolecular fluorescence complementation. J Biol Chem 289:
176. Marshall AM, Nommsen-Rivers LA, Hernandez LL, Dewey KG,
7275–7292, 2014.
Chantry CJ, Gregerson KA, Horseman ND. Serotonin transport and
153. Latuga MS, Stuebe A, Seed PC. A review of the source and function of
metabolism in the mammary gland modulates secretory activation and
microbiota in breast milk. Semin Reprod Med 32: 68 –73, 2014.
involution. J Clin Endocrinol Metab 95: 837–846, 2010.
154. Lauring J, Park BH, Wolff AC. The phosphoinositide-3-kinase-Akt- 177. Marshall I, Mehta R, Petrova A. Vitamin D in the maternal-fetal-
mTOR pathway as a therapeutic target in breast cancer. J Natl Compr neonatal interface: clinical implications and requirements for supplemen-
Canc Netw 11: 670 –678, 2013. tation. J Matern Fetal Neonatal Med 26: 633–638, 2013.
155. Le TN, Elsea SH, Romero R, Chaiworapongsa T, Francis GL. 178. Martins LF, Milazzotto MP, Feitosa WB, Coutinho AR, Simoes R,
Prolactin receptor gene polymorphisms are associated with gestational Marques MG, Assumpcao ME, Visintin JA. Sequence variation of the
diabetes. Genet Test Mol Biomarkers 17: 567–571, 2013. alpha-lactalbumin gene in Holstein and Nellore cows. Anim Biotechnol
156. Le TT, Rehrer CW, Huff TB, Nichols MB, Camarillo IG, Cheng JX. 19: 194 –198, 2008.
Nonlinear optical imaging to evaluate the impact of obesity on mammary 179. Matias SL, Dewey KG, Quesenberry CP Jr, Gunderson EP. Maternal
gland and tumor stroma. Mol Imaging 6: 205–211, 2007. prepregnancy obesity and insulin treatment during pregnancy are inde-
157. Lee E, Hsu C, Van den Berg D, Ursin G, Koh WP, Yuan JM, Stram pendently associated with delayed lactogenesis in women with recent
DO, Yu MC, Wu AH. Genetic variation in peroxisome proliferator- gestational diabetes mellitus. Am J Clin Nutr 99: 115–121, 2014.
activated receptor gamma, soy, and mammographic density in Singapore 180. Matsumoto C, Miyaura C, Ito A. Dietary Bisphenol A Suppresses the
Chinese women. Cancer Epidemiol Biomarkers Prev 21: 635–644, 2012. Growth of Newborn Pups by Insufficient Supply of Maternal Milk in
158. Lee S, Hennigar SR, Alam S, Nishida K, Kelleher SL. Essential Role Mice. J Health Sci 50: 315–318, 2004.
for Zinc Transporter 2 (ZnT2)-mediated Zinc Transport in Mammary 181. Matsuno AY, Esrey KL, Perrault H, Koski KG. Low intensity exer-
Gland Development and Function during Lactation. J Biol Chem 290: cise and varying proportions of dietary glucose and fat modify milk and
13064 –13078, 2015. mammary gland compositions and pup growth. J Nutr 129: 1167–1175,
159. Lemay DG, Ballard OA, Hughes MA, Morrow AL, Horseman ND, 1999.
Nommsen-Rivers LA. RNA sequencing of the human milk fat layer 182. Maxa J, Neuditschko M, Russ I, Forster M, Medugorac I. Genome-
transcriptome reveals distinct gene expression profiles at three stages of wide association mapping of milk production traits in Braunvieh cattle. J
lactation. PLoS One 8: e67531, 2013. Dairy Sci 95: 5357–5364, 2012.
160. Lemay DG, Pollard KS, Martin WF, Freeman Zadrowski C, Her- 183. McClellan HL, Hepworth AR, Kent JC, Garbin CP, Williams TM,
nandez J, Korf I, German JB, Rijnkels M. From genes to milk: Hartmann PE, Geddes DT. Breastfeeding frequency, milk volume, and
genomic organization and epigenetic regulation of the mammary tran- duration in mother-infant dyads with persistent nipple pain. Breastfeed
scriptome. PLoS One 8: e75030, 2013. Med 7: 275–281, 2012.
161. Lepe M, Bacardí Gascón M, Castañeda-González LM, Pérez Mo- 184. McCormick NH, Hennigar SR, Kiselyov K, Kelleher SL. The biology
rales ME, Jiménez Cruz A. Effect of maternal obesity on lactation: of zinc transport in mammary epithelial cells: implications for mammary
systematic review. Nutr Hosp 26: 1266 –1269, 2011. gland development, lactation, and involution. J Mammary Gland Biol
162. Li R, Fein SB, Chen J, Grummer-Strawn LM. Why mothers stop Neoplasia 19: 59 –71, 2014.
breastfeeding: mothers’ self-reported reasons for stopping during the first 185. McCormick NH, Kelleher SL. ZnT4 provides zinc to zinc-dependent
year. Pediatrics 122, Suppl 2: S69 –S76, 2008. proteins in the trans-Golgi network critical for cell function and Zn
227. Patton S, Jensen RS. Biomedical Aspects of Lactation: With Special 252. Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P, Thul-
Reference to Lipid Metabolism and Membrane Functions of the Mam- len J, Tingelstad J, Tully M. Polychlorinated biphenyls (PCBs) and
mary Gland. Oxford, UK: Pergamon, 1976. dichlorodiphenyl dichloroethene (DDE) in human milk: effects on
228. Pau MY, Milner JA. Effect of arginine deficiency on mammary gland growth, morbidity, and duration of lactation. Am J Public Health 77:
development in the rat. J Nutr 112: 1827–1833, 1982. 1294 –1297, 1987.
229. Peaker M, Wilde CJ. Feedback control of milk secretion from milk. J 253. Ronayne de Ferrer PA, Baroni A, Sambucetti ME, López NE,
Mammary Gland Biol Neoplasia 1: 307–315, 1996. Ceriani Cernadas JM. Lactoferrin levels in term and preterm milk. J
230. Peel CJ, Fronk TJ, Bauman DE, Gorewit RC. Effect of exogenous Am Coll Nutr 19: 370 –373, 2000.
growth hormone in early and late lactation on lactational performance of 254. Saben JL, Bales ES, Jackman MR, Orlicky D, MacLean PS, McMa-
dairy cows. J Dairy Sci 66: 776 –782, 1983. naman JL. Maternal obesity reduces milk lipid production in lactating
231. Peters JM. Hypernatremia in breast-fed infants due to elevated breast mice by inhibiting acetyl-CoA carboxylase and impairing fatty acid
milk sodium. J Am Osteopath Assoc 89: 1165–1170, 1989. synthesis. PLoS One 9: e98066, 2014.
232. Petersson Grawé K, Oskarsson A. Cadmium in milk and mammary 255. Sakalidis VS, Williams TM, Hepworth AR, Garbin CP, Hartmann
gland in rats and mice. Arch Toxicol 73: 519 –527, 2000. PE, Paech MJ, Al-Tamimi Y, Geddes DT. A comparison of early
233. Pettibone DJ, Woyden CJ, Totaro JA. Identification of functional sucking dynamics during breastfeeding after cesarean section and vaginal
oxytocin receptors in lactating rat mammary gland in vitro. Eur J birth. Breastfeed Med 8: 79 –85, 2013.
Pharmacol 188: 235–241, 1990. 256. Sallam SM, Nasser ME, Yousef MI. Effect of recombinant bovine
234. Picciano MF. Pregnancy and lactation: physiological adjustments, nu- somatotropin on sheep milk production, composition and some hemato-
tritional requirements and the role of dietary supplements. J Nutr 133: biochemical components. Small Rumin Res 56: 165–171, 2005.
1997S–2002S, 2003. 257. Sankaran L, Topper YJ. Effect of vitamin A deprivation on mainte-
235. Powe CE, Puopolo KM, Newburg DS, Lonnerdal B, Chen C, Allen nance of rat mammary tissue and on the potential of the epithelium for
M, Merewood A, Worden S, Welt CK. Effects of recombinant human hormone-dependent milk protein synthesis. Endocrinology 111: 1061–
prolactin on breast milk composition. Pediatrics 127: e359 –e366, 2011. 1067, 1982.
236. Prentice A. Should lactating women exercise? Nutr Rev 52: 358 –360, 258. Sanz-Moreno A, Fuhrmann D, Wolf E, von Eyss B, Eilers M,
1994. Elsasser HP. Miz1 deficiency in the mammary gland causes a lactation
237. Prentice AM, Prentice A. Energy costs of lactation. Annu Rev Nutr 8: defect by attenuated Stat5 expression and phosphorylation. PLoS One 9:
63–79, 1988. e89187, 2014.
238. Prinzenberg EM, Jianlin H, Erhardt G. Genetic variation in the 259. Savino F, Benetti S, Liguori SA, Sorrenti M, Cordero Di Monteze-
kappa-casein gene (CSN3) of Chinese yak (Bos grunniens) and phylo- molo L. Advances on human milk hormones and protection against
genetic analysis of CSN3 sequences in the genus Bos. J Dairy Sci 91: obesity. Cell Mol Biol (Noisy-le-grand) 59: 89 –98, 2013.
1198 –1203, 2008. 260. Saxena A, Sampson JR. Phenotypes associated with inherited and
239. Quintas-Cardama A, Verstovsek S. Molecular pathways: Jak/STAT developmental somatic mutations in genes encoding mTOR pathway
components. Semin Cell Dev Biol 36: 140 –146, 2014.
pathway: mutations, inhibitors, and resistance. Clin Cancer Res 19:
261. Schennink A, Stoop WM, Visker MH, Heck JM, Bovenhuis H, van
1933–1940, 2013.
der Poel JJ, van Valenberg HJ, van Arendonk JA. DGAT1 underlies
240. Rahmatalla SA, Muller U, Strucken EM, Reissmann M, Brockmann
large genetic variation in milk-fat composition of dairy cows. Anim
GA. The F279Y polymorphism of the GHR gene and its relation to milk
Genet 38: 467–473, 2007.
production and somatic cell score in German Holstein dairy cattle. J Appl
262. Scheplyagina LA. Impact of the mother’s zinc deficiency on the wom-
Genet 52: 459 –465, 2011.
an’s and newborn’s health status. J Trace Elem Med Biol 19: 29 –35,
241. Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and
2005.
meta-analysis on vitamin D receptor polymorphisms and cancer risk.
263. Semba RD, Kumwenda N, Taha TE, Hoover DR, Lan Y, Eisinger W,
Carcinogenesis 30: 1170 –1180, 2009.
Mtimavalye L, Broadhead R, Miotti PG, Van Der Hoeven L, Chip-
242. Rakicioglu N, Samur G, Topcu A, Topcu AA. The effect of Ramadan hangwi JD. Mastitis and immunological factors in breast milk of lactat-
on maternal nutrition and composition of breast milk. Pediatr Int 48: ing women in Malawi. Clin Diagn Lab Immunol 6: 671–674, 1999.
278 –283, 2006. 264. Shi DS, Wang J, Yang Y, Lu FH, Li XP, Liu QY. DGAT1, GH, GHR,
243. Ramsay DT, Kent JC, Hartmann RA, Hartmann PE. Anatomy of the PRL and PRLR polymorphism in water buffalo (Bubalus bubalis).
lactating human breast redefined with ultrasound imaging. J Anat 206: Reprod Domest Anim 47: 328 –334, 2012.
525–534, 2005. 265. Shi H, Luo J, Zhu J, Li J, Sun Y, Lin X, Zhang L, Yao D, Shi H.
244. Rasmussen KM. Association of maternal obesity before conception with PPAR ␥ Regulates Genes Involved in Triacylglycerol Synthesis and
poor lactation performance. Annu Rev Nutr 27: 103–121, 2007. Secretion in Mammary Gland Epithelial Cells of Dairy Goats. PPAR Res
245. Rasmussen KM, Kjolhede CL. Prepregnant overweight and obesity 2013: 310948, 2013.
diminish the prolactin response to suckling in the first week postpartum. 266. Sibeko L, Dhansay MA, Charlton KE, Johns T, Gray-Donald K.
Pediatrics 113: e465–e471, 2004. Beliefs, attitudes, and practices of breastfeeding mothers from a periur-
246. Raven LA, Cocks BG, Goddard ME, Pryce JE, Hayes BJ. Genetic ban community in South Africa. J Hum Lact 21: 31–38, 2005.
variants in mammary development, prolactin signalling and involution 267. Sigman M, Lonnerdal B. Response of rat mammary gland transferrin
pathways explain considerable variation in bovine milk production and receptors to maternal dietary iron during pregnancy and lactation. Am J
milk composition. Genet Sel Evol 46: 29, 2014. Clin Nutr 52: 446 –450, 1990.
247. Rayner JL, Enoch RR, Fenton SE. Adverse effects of prenatal expo- 268. Singh PP, Singh M, Mastana SS. APOE distribution in world popula-
sure to atrazine during a critical period of mammary gland growth. tions with new data from India and the UK. Ann Hum Biol 33: 279 –308,
Toxicol Sci 87: 255–266, 2005. 2006.
248. Reinhardt TA, Lippolis JD, Shull GE, Horst RL. Null mutation in the 269. Smilowitz JT, Lebrilla CB, Mills DA, German JB, Freeman SL.
gene encoding plasma membrane Ca2⫹-ATPase isoform 2 impairs Breast milk oligosaccharides: structure-function relationships in the ne-
calcium transport into milk. J Biol Chem 279: 42369 –42373, 2004. onate. Annu Rev Nutr 34: 143–169, 2014.
249. Rennison ME, Kerr M, Addey CV, Handel SE, Turner MD, Wilde 270. Smith RM, Leach RM, Muller LD, Griel LC Jr, Baker DE. Effects of
CJ, Burgoyne RD. Inhibition of constitutive protein secretion from long-term dietary cadmium chloride on tissue, milk, and urine mineral
lactating mouse mammary epithelial cells by FIL (feedback inhibitor of concentrations of lactating dairy cows. J Anim Sci 69: 4088 –4096, 1991.
lactation), a secreted milk protein. J Cell Sci 106: 641–648, 1993. 271. Standl M, Sausenthaler S, Lattka E, Koletzko S, Bauer CP, Wich-
250. Rijnkels M, Freeman-Zadrowski C, Hernandez J, Potluri V, Wang mann HE, von Berg A, Berdel D, Kramer U, Schaaf B, Lehmann I,
L, Li W, Lemay DG. Epigenetic modifications unlock the milk protein Herbarth O, Klopp N, Koletzko B, Heinrich J, Giniplus, Group LIS.
gene loci during mouse mammary gland development and differentiation. FADS gene cluster modulates the effect of breastfeeding on asthma.
PLoS One 8: e53270, 2013. Results from the GINIplus and LISAplus studies. Allergy 67: 83–90,
251. Rillema JA, Yu TX, Jhiang SM. Effect of prolactin on sodium iodide 2012.
symporter expression in mouse mammary gland explants. Am J Physiol 272. Stelwagen K, Singh K. The role of tight junctions in mammary gland
Endocrinol Metab 279: E769 –E772, 2000. function. J Mammary Gland Biol Neoplasia 19: 131–138, 2014.
313. Zhang X, Zhao F, Si Y, Huang Y, Yu C, Luo C, Zhang N, Li Q, Gao 315. Zimmerman DR, Goldstein L, Lahat E, Braunstein R, Stahi D,
X. GSK3beta regulates milk synthesis in and proliferation of dairy cow Bar-Haim A, Berkovitch M. Effect of a 24⫹ hour fast on breast milk
mammary epithelial cells via the mTOR/S6K1 signaling pathway. Mol- composition. J Hum Lact 25: 194 –198, 2009.
ecules 19: 9435–9452, 2014. 316. Zuppa AA, Sindico P, Orchi C, Carducci C, Cardiello V, Rom-
314. Zhu JJ, Luo J, Wang W, Yu K, Wang HB, Shi HB, Sun YT, Lin XZ, agnoli C. Safety and efficacy of galactogogues: substances that
Li J. Inhibition of FASN reduces the synthesis of medium-chain fatty induce, maintain and increase breast milk production. J Pharm Pharm
acids in goat mammary gland. Animal 8: 1469 –1478, 2014. Sci 13: 162–174, 2010.